SCHEMBL6747668

SCHEMBL6747668

c1ccc(-c2ccc(-c3sc(-c4ccc(-c5ccccn5)nc4)c4c3OCCO4)cn2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.43
KDM4E B2RXH2 6/20 0.41
LMNA P02545 3/20 0.41
P4HTM Q9NXG6 2/20 0.41
CCR1 P32246 2/20 0.41
CCR5 P51681 2/20 0.41
CCR8 P51685 2/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
METAP1 P53582 1/20 0.41
BLM P54132 1/20 0.41
HIF1A Q16665 1/20 0.41
DOHH Q9BU89 1/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
TP53 P04637 2/20 0.41
ALOX15 P16050 2/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747686 0.92 KDM4E (0.45) HPGDSKDM4ELMNAP4HTMCCR1
SCHEMBL6744236 0.81 KDM4E (0.50) HPGDSKDM4ELMNAP4HTMCCR1
SCHEMBL14441074 0.79 CCR1 (0.32) CCR1CCR5CCR8
SCHEMBL6744259 0.79 KDM4E (0.56) KDM4ELMNAP4HTMCCR1CCR5
SCHEMBL6747698 0.78 HPGDS (0.43) HPGDSKDM4ELMNAP4HTMCCR1
SCHEMBL6743821 0.77 HPGDS (0.52) HPGDSKDM4ELMNAP4HTMCCR1
SCHEMBL21636881 0.75 KDM4E (0.67) HPGDSKDM4ELMNAP4HTMCCR1
SCHEMBL18806862 0.75 KDM4E (0.67) HPGDSKDM4ELMNAP4HTMCCR1
SCHEMBL6744919 0.75 HPGDS (0.43) HPGDSKDM4ELMNAP4HTMCCR1
SCHEMBL9971712 0.75 CD274 (0.31) NPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696182-B2 HIGH PERFORMANCE DIPYRIDYL THIOPHENE OR DIPYRIDYL THIOPHENE DIOXIDE ELECTRON TRANSPORT MATERIALS WHICH WHEN EMPLOYED CAN GIVE LOW-VOLTAGE, HIGH EFFICIENCY ORGANIC ELECTROLUMINESCENT DEVICES CHISSO CORPORATION (JP) 2004-02-24 US disclosed
EP-1186605-B1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORP (JP) 2003-04-16 EP disclosed
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-21 US disclosed
EP-1186605-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative LAGE3, MAL2, ELF3 HPGDS 2727/4885KDM4E 276/4885LMNA 2640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.